Skip to main content
. 2021 Jun 3;11(6):106. doi: 10.1038/s41408-021-00498-0

Fig. 5. HDM, high-dose melphalan; VMP, bortezomib-melphalan-prednisone; PFS, progression-free survival; OS, overall survival; ITT, intention-to-treat; pts, patients.

Fig. 5

A Progression-free survival in the intention-to-treat population by treatment. B Overall survival in the intention-to-treat population by treatment.